2. Transdermally (through the skin) in creams, gels, patches and sprays
Regular check-ups are needed to monitor symptoms and any side effects
Dosages may be needed to be altered and it may be necessary to provide other additional medications
The boy from Aneja was prescribed 5 different drugs at one point
His case reveals how complex it can be to get the combination right for each individual
Typical antipsychotics
The first-generation (early) antipsychotics that were developed in the 1950s
Chlorpromazine
The first of these typical antipsychotic drugs
Haloperidol
Also blocks dopamine receptors like typical antipsychotics
Typical antipsychotic drugs
Block dopamine receptors on the postsynaptic cell, without activating them
Blocking dopamine receptors
Leads to less dopamine activity
Dopamine antagonists
Effective in reducing positive symptoms of schizophrenia
Side effects and relapse can be unpleasant, debilitating and even fatal
Side effects
Dizziness
Drowsiness
Restlessness
Nausea
Constipation
Excessiveweightgain
Side effects often lead to tardive dyskinesia (TD) or extrapyramidal symptoms (EPSS) (both characterized by uncontrollable blinking, jerking and twitching of the face and body)
Atypical antipsychotics
Drugs that block both dopamine and serotonin (an inhibitory neurotransmitter) receptors
Atypical antipsychotics
clozapine
risperidone
Atypical antipsychotics
Effective in reducing both negative and positive symptoms of schizophrenia
They rapidly dissociate (only block dopamine activity for a short period of time)
The rapid dissociation allows for normal dopamine transmission to take place less side effects
Atypical antipsychotics
Have fewer side effects but come with their own issues
Clozapine
Can cause agranulocytosis (a potentially fatal blood condition, although the risk is minimised through regular blood counts)
Side effects and relapse
Can lead people to stop taking their medications (non-compliance)
Non-compliance can be dangerous without the support of a professional
Texas Medication Algorithm Project (TMAP)
Designed to assist doctors in the prescription of antipsychotics
TMAP protocol
1. Initially use an atypical drug, such as risperidone
2. If that does not work, move onto a typical drug, such as haloperidol, or a different atypical such as olanzapine
3. If the person still does not find any relief, trial clozapine
Patients resistant to biochemical interventions
Final stages of TMAP include combining antipsychotics with other types of medication, such as mood stabilisers like lithium
When doctors have exhausted medication options
Move onto the use of electroconvulsive therapy
Randomised control trials (RCTs)
A study where the participants are randomly assigned to either the treatment or the control condition
RCTs are used to research the use of antipsychotic drugs
RCTs
They are often double-blind placebo controlled
50% of those taking antipsychotic medication show significant improvement in their condition after 4-6 weeks
30-40% show partial improvement
A substantial minority of those remaining show little to no improvement
The nomothetic approach allows generalisations to be made due to the very large sample size (Zhao, 2016)
The studies were longitudinal, lasting an average of 48 weeks (1-24 months)
The studies were assessed to determine their empirical quality using the Cochrane Risk of Bias Tool
The studies differed in terms of how relapse was measured but many used numerical rating scales
Positive and Negative Syndrome Scale (PANSS)
A common tool used to measure relapse, with high validity as it incorporates self-reported data as well as observations made by clinicians and caregivers (Opler, 2017)
These methodological features increase the overall validity of Zhao's findings, increasing confidence in the ability to apply the findings to others
When evaluating the efficacy of treatment
Idiographic approach may be beneficial
Studies using semistructured interviewing and/or focus groups
May be more likely to capture important details (like the role of perceived social support from family members and the nature of the therapeutic alliance between doctor and patient)